![Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling - ScienceDirect Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717411041-fx1.jpg)
Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling - ScienceDirect
![Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone - International Journal of Cardiology Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2037201382/2051759491/gr1.jpg)
Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone - International Journal of Cardiology
![Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/40a968ae-01ee-41d2-aa8a-0774c0b375e8/gr1.jpg)
Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology
![Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study | SpringerLink Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13300-021-01118-7/MediaObjects/13300_2021_1118_Fig1_HTML.png)